Tilarginine acetate April 12, 2017 Tilarginine acetate Trade Name Orphan Indication Cardiogenic shock USA Market Approval USA USA Designation Date 2005-04-11 00:00:00 Sponsor Arginox Pharmceuticals, Inc.;120 Constitution Drive;Menlo Park, California, 94025
